trending Market Intelligence /marketintelligence/en/news-insights/trending/hGlXu6wNVtp6ePYEI1gBKg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Report: PE investors in talks to buy India's animal healthcare company Sequent

Street Talk Episode 56 - Latest bank MOE shows even the strong need scale to thrive

South State CenterState MOE Shows Even The Strong Need Scale To Thrive

Talking Bank Stocks, Playing The M&A Trade With Longtime Investor

Report: Kashkari Says Fed In Holding Pattern But Rate Cut Still Possible

Report: PE investors in talks to buy India's animal healthcare company Sequent

Private equity investors including U.S.-based Advent International Corp. and India-based Kedaara Capital Investment Managers Ltd. are in early discussions to acquire Indian animal healthcare company Sequent Scientific Ltd., The Economic Times (India) reported, citing two people aware of the development.

A proposed deal is expected in the range of 25 billion Indian rupees, the publication said, citing the sources, who added that promoters and an existing private equity investor will exit. JP Morgan is running the sale process, which will involve an open offer, the news outlet noted.

Private equity firm Ascent Capital Advisors owns a 5% stake in the listed company, and the founder promoters of Sequent own a combined about 56.5% stake.

Representatives for Advent and Sequent declined to comment, while Kedaara did not respond to a request for comment by the publication.

As of Jan. 15, US$1 was equivalent to 70.71 Indian rupees.